Inovio Biomedical Corp (NASDAQ:INO)

CAPS Rating: 2 out of 5

A biomedical company which deals in developing human applications of electroporation, which uses brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceuticals.


Player Avatar neoexmnist (< 20) Submitted: 12/18/2012 7:35:47 AM : Outperform Start Price: $2.12 INO Score: +274.02

This company is tackling major diseases such as cancer, flu, and HIV. Their recent trial of the genetic vaccine for influenza yielded positive results and looks to continue in the same direction.

Featured Broker Partners